INIS
abscesses
10%
adults
7%
amplification
5%
antibiotics
30%
asia
6%
assessments
9%
bacillus
8%
bacteria
20%
biological markers
5%
blood
18%
bones
6%
brucella
5%
cerebrospinal fluid
6%
classification
5%
communities
19%
comparative evaluations
14%
concentration
7%
control
33%
correlations
5%
cost
10%
covid-19
11%
data
15%
detection
30%
diseases
37%
distribution
7%
drugs
6%
dynamics
7%
encephalitis
10%
environment
5%
epidemiology
19%
errors
6%
escherichia coli
8%
evaluation
10%
fever
7%
gene mutations
5%
genes
25%
genetics
6%
hepatitis
5%
hospitals
86%
host
7%
humans
18%
images
9%
income
6%
india
100%
infectious diseases
5%
influenza
11%
injuries
6%
kidneys
6%
laboratories
11%
levels
14%
liver
6%
losses
5%
management
9%
morbidity
6%
mortality
26%
mutations
6%
nepal
5%
optimization
6%
osteomyelitis
6%
pathogens
18%
patients
97%
pcr
10%
pneumonia
15%
resources
8%
reviews
25%
risks
36%
sensitivity
9%
sensors
5%
solutions
6%
stains
8%
staphylococcus
24%
strains
7%
substrates
5%
surgery
7%
surveillance
27%
surveys
14%
teaching
7%
testing
6%
therapy
11%
tissues
5%
transmission
7%
tuberculosis
10%
units
19%
values
5%
variations
7%
virulence
10%
viruses
32%
vitamin d
5%
waste water
5%
world health organization
7%
Medicine and Dentistry
Abscess
7%
Antibiotics
5%
Awareness
5%
Bloodstream Infection
8%
Burkholderia pseudomallei
12%
Cohort Effect
9%
Community-Acquired Pneumonia
6%
COVID-19
8%
Disease
13%
Health Care
5%
Health Care Cost
5%
Healthcare Associated Infection
9%
Infection
22%
Infection Control
10%
Infection Prevention
9%
Intensive Care Unit
9%
Melioidosis
49%
Methicillin Resistant Staphylococcus Aureus
8%
Meticillin
6%
Observational Study
7%
Pathogen
9%
Prevalence
6%
Probiotic Agent
5%
Retrospective Cohort Study
6%
Sepsis
10%
Staphylococcus Aureus
7%
Tertiary Care
20%
Ventilator-Associated Pneumonia
5%
Pharmacology, Toxicology and Pharmaceutical Science
Antibiotic Resistance
14%
Antibiotics
12%
Antiinfective Agent
15%
Antimicrobial Resistance
13%
Antivirus Agent
6%
Bloodstream Infection
5%
Chronic Osteomyelitis
6%
Cohort Study
5%
Disease
9%
Epidemiology
5%
Escherichia coli
8%
Hospital Infection
6%
Infection
24%
Melioidosis
14%
Methicillin Resistant Staphylococcus Aureus Infection
5%
Methicillin-Resistant Staphylococcus Aureus
8%
Osteomyelitis
5%
Prevalence
12%
Probiotic Agent
6%
Respiratory Tract Infection
5%
Silver Nanoparticle
5%
Staphylococcus Aureus
12%
Vitamin D
5%